Health Care/Hospital
Waterdrop Files Annual Report on Form 20-F for Fiscal Year 2022
BEIJING, April 17, 2023 /PRNewswire/ -- Waterdrop Inc. ("Waterdrop", the "Company" or "we") (NYSE: WDH), a leading technology platform dedicated to insurance and healthcare service with a positive social impact, today announced that it filed its annual report on Form 20-F for the fiscal year ende...
2023-04-17 20:24
2289
Antengene Announces Five Presentations at the 2023 American Association for Cancer Research Meeting
* Five posters showcased progress with multiple preclinical and clinical programs, includingATG-008 (mTORC1/2 inhibitor), ATG-017 (ERK1/2 inhibitor), ATG-037 (CD73 inhibitor), ATG-031 (anti-CD24 monoclonal antibody) and ATG-034 (LILRB4 antagonist antibody) * Clinical results showed promising ...
2023-04-17 20:22
2015
Orion Health launches Orchestral - a once in a generation giant leap forward for health data
Orchestral reimagines the aggregation of data and how it is used in healthcare in the modern machine learning era. AUCKLAND, New Zealand, April 17, 2023 /PRNewswire/ -- The Orchestral health intelligence platform, announced at HIMSS23, is the biggest step forward in health data since the advent ...
2023-04-17 20:00
1512
Asieris Releases 2022 Annual Report: Makes Steady Progress in its Clinical Development, Global Expansion to Treat Genitourinary Tumors, and Implementing its Commercialization Strategy to Provide Integrated Diagnosis-to-Treatment Solutions
SHANGHAI, April 17, 2023 /PRNewswire/ -- Asieris Pharmaceuticals(688176.SH), a global biopharma company specializing in the discovery, development and commercialization of innovative drugs that treat genitourinary (GU) tumors and other related diseases, today released its 2022 annual report. Whil...
2023-04-17 18:30
1774
Telix Reports Q1 2023 Financial Results: Delivers First $100M Revenue Quarter
MELBOURNE, Australia, April 17, 2023 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today issues its Appendix 4C quarterly cash flow statement and accompanying Activities Report for the quarter ended31 March 2023 (Q1 2023). All figures are in AUD$ unless otherwise st...
2023-04-17 18:15
2031
World Hemophilia Day 2023 - "Access for All: Prevention of bleeds as the global standard of care"
MONTREAL, April 17, 2023 /PRNewswire/ -- April 17, 2023 is World Hemophilia Day. The theme of the event this year is "Access for All: Prevention of bleeds as the global standard of care". Building on last year's theme, the call to action for the community in 2023 is to come together and advocate ...
2023-04-17 17:00
1363
Bassem Elmankabadi, M.D. joins Foresee Pharmaceuticals as a Senior Vice President of Clinical Development
TAIPEI, April 17, 2023 /PRNewswire/ -- Foresee Pharmaceuticals Co., Ltd. (6576.TWO) ("Foresee"), announces today thatBassem Elmankabadi, M.D. joins Foresee as a Senior Vice President of Clinical Development. Dr. Bassem Elmankabadi is a Board Certified Surgeon with over 17 years of clinical backg...
2023-04-17 16:50
1390
CT Event Asia to host the 3rd Annual ASEAN Healthcare Transformation Summit
KUALA LUMPUR, Malaysia, April 17, 2023 /PRNewswire/ -- This year, CT Asia is all set to bring you the 3rd Annual ASEAN Healthcare Transformation Summit, an exclusive platform for healthcare professionals, aiming to educate the masses on trending innovative technologies designed to personalize hea...
2023-04-17 15:27
1929
Late-Breaking Research - Alphamab Oncology Presents Preclinical Results of KN052 at AACR 2023
SUZHOU, China, April 17, 2023 /PRNewswire/ -- Alphamab Oncology (stock code: 9966.HK) announced that the preclinical result of KN052 (PD-L1/OX40 bispecific antibody) were presented as a poster at the Late-Breaking Research session of the AACR Annual Meeting 2023 (AACR 2023). The AACR Annual Meet...
2023-04-17 14:01
1863
EBMI INKED MOA WITH SFIO TO BUILD A WORLD-CLASSS INTEGRATIVE CARE FACILITY IN PALAWAN, PHILIPPINES
MANILA, Philippines, April 17, 2023 /PRNewswire/ -- European Biological Medicine Inc., a subsidiary of European Wellness Biomedical Group (EW Group) has inked a Memorandum of Agreement (MoA) with Starfleet Innotech, Inc. (SFIO) to build a world-class integrative care facility in Palawan,Philippin...
2023-04-17 11:00
2539
AffaMed Therapeutics Announces Approval to Initiate a Phase 3 Registrational Clinical Trial in Mainland China for DEXTENZA® for the Treatment of Ocular Inflammation and Pain Following Ophthalmic Surgery
SHANGHAI, April 17, 2023 /PRNewswire/ -- AffaMed Therapeutics ("AffaMed"), a global biotechnology company dedicated to developing and commercializing transformative pharmaceutical, digital and surgical products that address critical unmet medical needs in ophthalmological, neurological and psychi...
2023-04-17 09:00
4217
Innovent Releases Final Analysis Results of ORIENT-15: the Phase 3 Study of Sintilimab plus Chemotherapy for the First-Line Treatment of Esophageal Squamous Cell Carcinoma at the AACR Annual Meeting 2023
ROCKVILLE, Md. and SUZHOU, China, April 17, 2023 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of oncology, autoimmune, metabolic, ophthalmology a...
2023-04-17 08:33
3101
Abbisko presents the research results of 5 programs at the 2023 AACR Annual Meeting
SHANGHAI, April 17, 2023 /PRNewswire/ -- Abbisko (Stock Code: 2256.HK)
announced the results of five latest preclinical studies at the 2023 American
Association for Cancer Research (AACR) annual meeting.
2023-04-17 08:30
2993
Innovent Releases Final Analysis Results of ORIENT-15: the Phase 3 Study of Sintilimab plus Chemotherapy for the First-Line Treatment of Esophageal Squamous Cell Carcinoma at the AACR Annual Meeting 2023
ROCKVILLE, Md. and SUZHOU, China, April 16, 2023 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of oncology, autoimmune, metabolic, ophthalmology a...
2023-04-17 08:20
2930
Henlius Achieved Steep Revenue Growth in Q1 2023, Core Products Sales Surged
SHANGHAI, April 17, 2023 /PRNewswire/ -- As a global innovative biopharmaceutical company, Henlius is committed to offering high-quality, affordable and innovative biopharmaceuticals to patients worldwide with 5 products launched inChina. Leveraging the differentiated competitive edges of its pr...
2023-04-17 07:45
2058
Bugworks Research Inc. to Present Eight Posters at the 33rd European Congress of Clinical Microbiology & Infectious Diseases (ECCMID) 2023, in Copenhagen, Denmark
BANGALORE, India and DELAWARE CITY, Del. and ADELAIDE, Australia, April 17, 2023 /PRNewswire/ -- Bugworks Research Inc., a clinical-stage biopharmaceutical company, is set to present its latest research findings on the novel bacterial topoisomerase inhibitor, BWC0977 at the upcoming 33rd European...
2023-04-17 07:00
2128
Olaratumab Antibody Licensed from Lilly Demonstrates Proof of Concept as a Theranostic Radiopharmaceutical
MELBOURNE, Australia, April 17, 2023 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces successful preclinical development of radiolabelled olaratumab, an antibody licensed from Eli Lilly and Company (Lilly). Telix has demonstrated proof-of-concept (PoC) ...
2023-04-17 06:38
1736
Introducing the MetaSight® G200: A Revolutionary Third-Generation Chromosomal Karyotyping System Transforming Global Chromosomal Analysis
CHANGSHA, China, April 15, 2023 /PRNewswire/ -- The MetaSight® G200 is a groundbreaking karyotyping system based on high-resolution microscopy technology, capable of accurately detecting chromosomal abnormalities in humans. This innovative system aids doctors in diagnosing and treating diseases ...
2023-04-15 14:43
2964
BIOMERICS EXPANDS MANUFACTURING OPERATIONS IN TEXAS
SALT LAKE CITY, April 14, 2023 /PRNewswire/ -- Biomerics, the leading vertically integrated medical device contract manufacturer in the interventional device market, announced the completion of a 24,000 sq. ft. expansion of manufacturing operations at theirAthens, TX, facility. Driven by growth ...
2023-04-14 21:00
2215
Meihua International Medical Technologies Co., Ltd. Reports 2022 Financial Year Results
YANGZHOU, China, April 14, 2023 /PRNewswire/ -- Meihua International Medical Technologies Co., Ltd. ("MHUA" or the "Company") (NASDAQ: MHUA), a reputable manufacturer and provider of Class I, II and III disposable medical devices with operating subsidiaries inChina, today reported its financial r...
2023-04-14 20:45
3692
Week's Top Stories
Most Reposted
Multiple achievements made in China-Hungary BRI conference
[Picked up by 319 media titles]
2024-05-03 06:59
Shanghai Jiao Tong University Offers Free Online Courses for International Learners, Joint Programs with Tmall of Alibaba and Dow Gain High Popularity
[Picked up by 317 media titles]
2024-05-07 08:00
VentureBlick Launches 'Discovery': The First Global Networking Platform for Healthcare Innovation
[Picked up by 312 media titles]
2024-05-08 14:37
OPTIX raises US$15 million fundraising to date to solve the bottleneck of XR optics technology
[Picked up by 306 media titles]
2024-05-08 08:00IN2MF in Kuala Lumpur Presented by Bank Indonesia
[Picked up by 290 media titles]
2024-05-08 16:44
Most Read
/C O R R E C T I O N -- Addverb/
2024-05-03 20:26
14378
Multiple achievements made in China-Hungary BRI conference
2024-05-03 06:59
9999
Xinhua president, Hungarian economy minister vow to bolster media cooperation
2024-05-03 06:25
9532
